The Effect of Smart Phone Application Supported Nursing Care Program
1 other identifier
interventional
102
0 countries
N/A
Brief Summary
Hypertension is an important public health problem in our country and in the world. For success in hypertension treatment, timely and accurate diagnosis of patients, effective implementation of lifestyle changes, timely initiation of drug therapy and effective drug compliance are emphasized. The rapid adoption of smartphone technology provides a promising platform for overcoming drug non-compliance by providing medication intake reminders, healthy lifestyle education. It is emphasized that the health belief model can be used in the self-management of the hypertension patient's health and in the regulation of services with smart phone applications. Based on these facts, this study was planned to examine the effect of the smart phone management system supported nursing care program given by the nurse to the primary hypertension patients registered in the Family Health Center on the patient's compliance with the treatment and the blood pressure staying within the target limits. The research was organized in an experimental design with pre-test post-test control group. The population of the research consists of primary hypertensive patients registered in Family Health Centers in Tosya district of Kastamonu province. It is planned to include a total of 102 people, 51 in the intervention and control groups, in the sample group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started May 2022
Shorter than P25 for not_applicable hypertension
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2022
CompletedStudy Start
First participant enrolled
May 25, 2022
CompletedFirst Posted
Study publicly available on registry
May 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedMay 26, 2022
May 1, 2022
6 months
May 23, 2022
May 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
There is a difference in time (pre-test, after intervention, 1st month, 3rd month, 6th month) between intervention and control group patients' self-efficacy scale scores of adherence to drug therapy.
Drug Adherence/Compliance Self-Efficacy Scale
0-6 month
Secondary Outcomes (1)
There is a difference in time (pre-test, after the intervention, 1st month, 3rd month, 6th month) between the patients in the intervention and control groups having normal systolic and diastolic blood pressure measurements.
0-6 month
Study Arms (2)
intervention group.
EXPERIMENTALHealth belief model-based smartphone-assisted nursing care program application will be installed on the phones of the patients who will be in the intervention group.
non-intervention group
ACTIVE COMPARATORstandard care practice will continue
Interventions
Health belief model-based smartphone-assisted nursing care program application will be installed on the phones of the patients who will be in the intervention group.
Eligibility Criteria
You may qualify if:
- Agreeing to participate in the research.
- Being between 45-64 years old
- At least primary school graduate
- Using antihypertensive medication for at least 6 months with the diagnosis of primary (essential) hypertension.
- Owning a smart phone
You may not qualify if:
- Being diagnosed with secondary hypertension Have been diagnosed with pregnancy-onset hypertension
- Hearing, seeing and understanding problems Having a diagnosis of dementia and alzheimer's
- Diagnosed with chronic kidney failure
- Being a dialysis patient
- History of myocardial infarction, stroke, diagnosis of heart failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kastamonu Universitylead
- Ege Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zeynep ARABACI
Kastamonu University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
May 23, 2022
First Posted
May 26, 2022
Study Start
May 25, 2022
Primary Completion
November 25, 2022
Study Completion
December 30, 2022
Last Updated
May 26, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share